AtriCure
ATRC
217 hedge funds and large institutions have $2.89B invested in AtriCure in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 85 reducing their positions, and 26 closing their positions.
4% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 26
0% more funds holding
Funds holding: 217 → 217 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.38% less ownership
Funds ownership: 96.06% → 95.68% (-0.38%)
4% less capital inflows, than outflows
Capital inflows: $158M | Capital outflows: $164M
9% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 85
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$27.7M |
| 2 |
First Light Asset Management
Edina,
Minnesota
|
+$23.3M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$23.1M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.8M |
| 5 |
Bellevue Group
Kuesnacht,
Switzerland
|
+$6.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fred Alger Management
New York
|
-$31.2M |
| 2 |
Millennium Management
New York
|
-$15.5M |
| 3 |
TimesSquare Capital Management
New York
|
-$12.2M |
| 4 |
Bank of New York Mellon
New York
|
-$10.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.9M |
ATRC Hedge Fund Activity: Q1 2022 in Review
217 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2022, worth a combined $2.89B — down 5.7% from $3.07B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ATRC positions and 26 closed out — a net gain of 1 holder — while 77 added to existing stakes and 85 trimmed.
The largest buyer was Invesco, adding an estimated $27.7M. The largest seller was Fred Alger Management, cutting an estimated $31.2M.
- 217 institutional investors held AtriCure (ATRC) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $2.89B of AtriCure stock for Q1 2022, down 5.7% quarter-over-quarter.
- 27 funds opened new AtriCure positions in Q1 2022 and 26 closed out, a net change of +1 holder.
- The largest AtriCure buyer in Q1 2022 was Invesco, an estimated $27.7M added.
- The largest AtriCure seller in Q1 2022 was Fred Alger Management, an estimated $31.2M sold.
Based on aggregated 13F filings for Q1 2022.